Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis

  • Chunbo Tang
  • Ning Chen
  • Mingyue Wu
  • Hua Yuan
  • Yifei Du


Several polymorphisms in the vitamin D receptor (VDR) gene have been reported to influence breast cancer risk. However, the published findings have been conflicting. We conducted a meta-analysis of 21 case–control studies with Fok1 (eight studies with 5,284 cases and 7,500 controls), Bsm1 (14 studies with 5,498 cases and 7,943 controls), Apa1 (four studies with 1,138 cases and 7,943 controls), Taq1 (10 studies with 4,459 cases and 5,485 controls) polymorphisms. The results showed Fok1 polymorphism was associated with an overall significantly increased risk of breast cancer (ff vs. FF: OR = 1.15, 95% CI = 1.03–1.28; the recessive model ff vs. Ff + FF: OR = 1.14, 95% CI = 1.03–1.26). In subgroup analysis, a significant association was evident between Fok1 polymorphism and breast cancer in European population (ff vs. FF: OR = 1.16, 95% CI = 1.04–1.30; the recessive model ff vs. Ff + FF: OR = 1.15, 95% CI = 1.04–1.28). There was no between-study heterogeneity in any of these analyses. No significant associations were observed between the Bsm1, Apa1 and Taq1 variants and breast cancer risk. So, the current meta-analysis shows that Fok1 may be a susceptibility biomarker for breast cancer especially in European population.


VDR Fok1 Bsm1 Apa1 Taq1 Polymorphism Breast cancer Meta-analysis 


  1. 1.
    Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, Willett WC (2002) Intake of dairy products, calcium, and vitamin d and risk of breast cancer. J Natl Cancer Inst 94:1301–1311PubMedGoogle Scholar
  2. 2.
    Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, Hankinson SE (2005) Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 14:1991–1997. doi: 10.1158/1055-9965.EPI-04-0722 PubMedCrossRefGoogle Scholar
  3. 3.
    Colston K, Colston MJ, Fieldsteel AH, Feldman D (1982) 1,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines. Cancer Res 42:856–859PubMedGoogle Scholar
  4. 4.
    Townsend K, Banwell CM, Guy M, Colston KW, Mansi JL, Stewart PM, Campbell MJ, Hewison M (2005) Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin Cancer Res 11:3579–3586. doi: 10.1158/1078-0432.CCR-04-2359 PubMedCrossRefGoogle Scholar
  5. 5.
    John EM, Schwartz GG, Koo J, Wang W, Ingles SA (2007) Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol 166:1409–1419. doi: 10.1093/aje/kwm259 PubMedCrossRefGoogle Scholar
  6. 6.
    Fang Y, van Meurs JB, d’Alesio A, Jhamai M, Zhao H, Rivadeneira F, Hofman A, van Leeuwen JP, Jehan F, Pols HA, Uitterlinden AG (2005) Promoter and 3′-untranslated-region haplotypes in the vitamin d receptor gene predispose to osteoporotic fracture: the rotterdam study. Am J Hum Genet 77:807–823. doi: 10.1086/497438 PubMedCrossRefGoogle Scholar
  7. 7.
    Crofts LA, Hancock MS, Morrison NA, Eisman JA (1998) Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts. Proc Natl Acad Sci USA 95:10529–10534. doi: 10.1073/pnas.95.18.10529 PubMedCrossRefGoogle Scholar
  8. 8.
    Ruggiero M, Pacini S, Aterini S, Fallai C, Ruggiero C, Pacini P (1998) Vitamin D receptor gene polymorphism is associated with metastatic breast cancer. Oncol Res 10:43–46PubMedGoogle Scholar
  9. 9.
    Abbas S, Nieters A, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J (2008) Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res 10:R31. doi: 10.1186/bcr1994 PubMedCrossRefGoogle Scholar
  10. 10.
    Chen WY, Bertone-Johnson ER, Hunter DJ, Willett WC, Hankinson SE (2005) Associations between polymorphisms in the vitamin D receptor and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14:2335–2339. doi: 10.1158/1055-9965.EPI-05-0283 PubMedCrossRefGoogle Scholar
  11. 11.
    Curran JE, Vaughan T, Lea RA, Weinstein SR, Morrison NA, Griffiths LR (1999) Association of A vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer 83:723–726. doi :10.1002/(SICI)1097-0215(19991210)83:6<723::AID-IJC4>3.0.CO;2-3Google Scholar
  12. 12.
    Guy M, Lowe LC, Bretherton-Watt D, Mansi JL, Peckitt C, Bliss J, Wilson RG, Thomas V, Colston KW (2004) Vitamin D receptor gene polymorphisms and breast cancer risk. Clin Cancer Res 10:5472–5481. doi: 10.1158/1078-0432.CCR-04-0206 PubMedCrossRefGoogle Scholar
  13. 13.
    McCullough ML, Stevens VL, Diver WR, Feigelson HS, Rodriguez C, Bostick RM, Thun MJ, Calle EE (2007) Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res 9:R9. doi: 10.1186/bcr1642 PubMedCrossRefGoogle Scholar
  14. 14.
    Sinotte M, Rousseau F, Ayotte P, Dewailly E, Diorio C, Giguere Y, Berube S, Brisson J (2008) Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population. Endocr Relat Cancer 15(4):975–983PubMedCrossRefGoogle Scholar
  15. 15.
    Buyru N, Tezol A, Yosunkaya-Fenerci E, Dalay N (2003) Vitamin D receptor gene polymorphisms in breast cancer. Exp Mol Med 35:550–555PubMedGoogle Scholar
  16. 16.
    Hefler LA, Tempfer CB, Grimm C, Lebrecht A, Ulbrich E, Heinze G, Leodolter S, Schneeberger C, Mueller MW, Muendlein A, Koelbl H (2004) Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women. Cancer 101:264–269. doi: 10.1002/cncr.20361 PubMedCrossRefGoogle Scholar
  17. 17.
    Hou MF, Tien YC, Lin GT, Chen CJ, Liu CS, Lin SY, Huang TJ (2002) Association of vitamin D receptor gene polymorphism with sporadic breast cancer in Taiwanese patients. Breast Cancer Res Treat 74:1–7. doi: 10.1023/A:1016048900049 PubMedCrossRefGoogle Scholar
  18. 18.
    Ingles SA, Garcia DG, Wang W, Nieters A, Henderson BE, Kolonel LN, Haile RW, Coetzee GA (2000) Vitamin D receptor genotype and breast cancer in Latinas (United States). Cancer Causes Control 11:25–30. doi: 10.1023/A:1008979417618 PubMedCrossRefGoogle Scholar
  19. 19.
    Lowe LC, Guy M, Mansi JL, Peckitt C, Bliss J, Wilson RG, Colston KW (2005) Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer 41:1164–1169. doi: 10.1016/j.ejca.2005.01.017 PubMedCrossRefGoogle Scholar
  20. 20.
    Trabert B, Malone KE, Daling JR, Doody DR, Bernstein L, Ursin G, Marchbanks PA, Strom BL, Humphrey MC, Ostrander EA (2007) Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res 9:R84. doi: 10.1186/bcr1833 PubMedCrossRefGoogle Scholar
  21. 21.
    Sillanpaa P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K (2004) Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk. Pharmacogenetics 14:239–245. doi: 10.1097/00008571-200404000-00003 PubMedCrossRefGoogle Scholar
  22. 22.
    Dunning AM, McBride S, Gregory J, Durocher F, Foster NA, Healey CS, Smith N, Pharoah PD, Luben RN, Easton DF, Ponder BA (1999) No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis 20:2131–2135. doi: 10.1093/carcin/20.11.2131 PubMedCrossRefGoogle Scholar
  23. 23.
    Lundin AC, Soderkvist P, Eriksson B, Bergman-Jungestrom M, Wingren S (1999) Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group. Cancer Res 59:2332–2334PubMedGoogle Scholar
  24. 24.
    Little J, Bradley L, Bray MS, Clyne M, Dorman J, Ellsworth DL, Hanson J, Khoury M, Lau J, O’Brien TR, Rothman N, Stroup D, Taioli E, Thomas D, Vainio H, Wacholder S, Weinberg C (2002) Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 156:300–310PubMedGoogle Scholar
  25. 25.
    Guy M, Lowe LC, Bretherton-Watt D, Mansi JL, Colston KW (2003) Approaches to evaluating the association of vitamin D receptor gene polymorphisms with breast cancer risk. Recent Results Cancer Res 164:43–54PubMedGoogle Scholar
  26. 26.
    VandeVord PJ, Wooley PH, Darga LL, Severson RK, Wu B, Nelson DA (2006) Genetic determinants of bone mass do not relate with breast cancer risk in US white and African-American women. Breast Cancer Res Treat 100:103–107. doi: 10.1007/s10549-006-9228-6 PubMedCrossRefGoogle Scholar
  27. 27.
    Bretherton-Watt D, Given-Wilson R, Mansi JL, Thomas V, Carter N, Colston KW (2001) Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer 85:171–175. doi: 10.1054/bjoc.2001.1864 PubMedCrossRefGoogle Scholar
  28. 28.
    Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127:820–826PubMedGoogle Scholar
  29. 29.
    Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748PubMedGoogle Scholar
  30. 30.
    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188. doi: 10.1016/0197-2456(86)90046-2 PubMedCrossRefGoogle Scholar
  31. 31.
    Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634PubMedGoogle Scholar
  32. 32.
    Colston KW, Berger U, Coombes RC (1989) Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1:188–191. doi: 10.1016/S0140-6736(89)91204-X PubMedCrossRefGoogle Scholar
  33. 33.
    Fang Y, van Meurs JB, Bergink AP, Hofman A, van Duijn CM, van Leeuwen JP, Pols HA, Uitterlinden AG (2003) Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly. J Bone Miner Res 18:1632–1641. doi: 10.1359/jbmr.2003.18.9.1632 PubMedCrossRefGoogle Scholar
  34. 34.
    Colin EM, Weel AE, Uitterlinden AG, Buurman CJ, Birkenhager JC, Pols HA, van Leeuwen JP (2000) Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D3. Clin Endocrinol (Oxf) 52:211–216. doi: 10.1046/j.1365-2265.2000.00909.x CrossRefGoogle Scholar
  35. 35.
    Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K, Tonai T, Nishisho T, Mori S, Takeda E (1997) A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 12:915–921. doi: 10.1359/jbmr.1997.12.6.915 PubMedCrossRefGoogle Scholar
  36. 36.
    Newcomb PA, Kim H, Trentham-Dietz A, Farin F, Hunter D, Egan KM (2002) Vitamin D receptor polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 11:1503–1504PubMedGoogle Scholar
  37. 37.
    Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA (1994) Prediction of bone density from vitamin D receptor alleles. Nature 367:284–287. doi: 10.1038/367284a0 PubMedCrossRefGoogle Scholar
  38. 38.
    Beaumont M, Bennett AJ, White DA (1998) Allelic differences in the 3′untranslated region of the vitamin D receptor gene affect mRNA levels in bone cells. Osteoporos Int 8:37Google Scholar
  39. 39.
    Kremer R, Bolivar I, Goltzman D, Hendy GN (1989) Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 125:935–941PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2009

Authors and Affiliations

  • Chunbo Tang
    • 1
  • Ning Chen
    • 1
  • Mingyue Wu
    • 1
  • Hua Yuan
    • 1
  • Yifei Du
    • 1
  1. 1.Dental Research Institute, School of StomatologyNanjing Medical UniversityNanjingChina

Personalised recommendations